The study and its comparison
Two hundred fifteen older nursing-home residents were randomized to lozenges containing L. reuteri DSM 17938 and ATCC PTA 5289 or placebo twice daily for 12 weeks. Follow-up attrition was 19 percent. [1]
The probiotic group had a lower prevalence of high Candida counts in saliva and plaque than the comparator. Plaque levels and bleeding on probing did not significantly differ. [1]
What the finding establishes
The primary outcome was an organism-count threshold, not confirmed resolution of symptomatic thrush. Selected frail older adults and a two-strain oral formulation also limit transfer to swallowed capsules or other populations. Funding and conflicts were not established from the abstract. [1]
A hypothetical distinction
Imagine a saliva test crosses below a microbial threshold. That alone does not establish that a painful oral lesion has healed.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Effect of Probiotic Bacteria on Oral Candida in Frail Elderly.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.